Literature DB >> 15284903

Telomeres, telomerase, and apoptosis.

Chiara Mondello1, A Ivana Scovassi.   

Abstract

Telomeres are specialized high-order chromatin structures that cap the ends of eukaryotic chromosomes. In vertebrates, telomeric DNA is composed of repetitions of the TTAGGG hexanucleotide, is bound to a set of specific proteins, and is elongated by the reverse transcriptase enzyme telomerase. Telomerase activity is promptly detected in cells with an indefinite replicative potential, such as cancer cells, while is almost undetectable in normal cells, which are characterized by a limited life span. Mounting evidence indicates that the maintenance of telomere integrity and telomerase protect cells from apoptosis. Disruption of the telomere capping function and (or) telomerase inhibition elicit an apoptotic response in cancer cells, while restoration of telomerase activity in somatic cells confers resistance to apoptosis. The possible mechanisms linking telomeres, telomerase and apoptosis are discussed in this review, together with the impact of this field in anticancer research.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15284903     DOI: 10.1139/o04-048

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  15 in total

1.  Reversibility of replicative senescence in Saccharomyces cerevisiae: effect of homologous recombination and cell cycle checkpoints.

Authors:  Sandra C Becerra; Hiranthi T Thambugala; Alison Russell Erickson; Christopher K Lee; L Kevin Lewis
Journal:  DNA Repair (Amst)       Date:  2011-11-09

2.  Effects of cadmium on telomerase activity, expressions of TERT, c-myc and P53, and apoptosis of rat hepatocytes.

Authors:  Wentao Dai; Huajie Chen; Rian Yu; Lingfei He; Bing Chen; Xuemin Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-12-22

3.  Cell-free DNA and telomere length among women undergoing in vitro fertilization treatment.

Authors:  J Czamanski-Cohen; O Sarid; J Cwikel; A Douvdevani; E Levitas; E Lunenfeld; I Har-Vardi
Journal:  J Assist Reprod Genet       Date:  2015-10-05       Impact factor: 3.412

4.  Lung alveolar integrity is compromised by telomere shortening in telomerase-null mice.

Authors:  Jooeun Lee; Raghava Reddy; Lora Barsky; Jessica Scholes; Hui Chen; Wei Shi; Barbara Driscoll
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-10-24       Impact factor: 5.464

5.  An integrated molecular dynamics (MD) and experimental study of higher order human telomeric quadruplexes.

Authors:  Luigi Petraccone; Nichola C Garbett; Jonathan B Chaires; John O Trent
Journal:  Biopolymers       Date:  2010-06       Impact factor: 2.505

6.  In vitro and ex vivo inhibition of human telomerase by anti-HIV nucleoside reverse transcriptase inhibitors (NRTIs) but not by non-NRTIs.

Authors:  Kyle R Hukezalie; Naresh R Thumati; Hélène C F Côté; Judy M Y Wong
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

7.  Using antimicrobial adjuvant therapy in cancer treatment: a review.

Authors:  Kenneth Alibek; Aliya Bekmurzayeva; Assel Mussabekova; Bolat Sultankulov
Journal:  Infect Agent Cancer       Date:  2012-11-20       Impact factor: 2.965

8.  Overexpression of Telomerase Protects Human and Murine Lung Epithelial Cells from Fas- and Bleomycin-Induced Apoptosis via FLIP Upregulation.

Authors:  Nissim Arish; Pazit Y Cohen; Regina Golan-Gerstl; Zvi Fridlender; Mark Richter Dayan; Philip Zisman; Raphael Breuer; Shulamit B Wallach-Dayan
Journal:  PLoS One       Date:  2015-05-07       Impact factor: 3.240

9.  Telomere-independent functions of telomerase in nuclei, cytoplasm, and mitochondria.

Authors:  Ilaria Chiodi; Chiara Mondello
Journal:  Front Oncol       Date:  2012-09-28       Impact factor: 6.244

10.  RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells.

Authors:  André O von Bueren; Tarek Shalaby; Christoph Oehler-Jänne; Lucia Arnold; Duncan Stearns; Charles G Eberhart; Alexandre Arcaro; Martin Pruschy; Michael A Grotzer
Journal:  BMC Cancer       Date:  2009-01-10       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.